Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

Dextromethorphan Pediatric Acute Cough Study